Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guglielmo Migliorino

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The New England Journal of Medicine|October 30, 2014
Brain abscessSebastiano Leone, Guglielmo Migliorino, Andrea Gori
The Journal of Antimicrobial Chemotherapy|March 12, 2011
Lung cryptococcosis in a treated HIV-1-infected patient with suppressed viral load and past disseminated cryptococcosis: relapse or late IRIS?Alessandro Soria, Monica Airoldi, Guglielmo Migliorino, et al.
Folia Neuropathologica|October 2, 2012
Primary angiitis of the central nervous system: 2 atypical casesFabio Pagni, Giuseppe Isimbaldi, Francesco Vergani, et al.
BMC Research Notes|August 8, 2014
The CCR5Δ32 allele is not a major predisposing factor for severe H1N1pdm09 infectionManuela Sironi, Rachele Cagliani, Chiara Pontremoli, et al.
Journal of Medical Microbiology|January 28, 2012
Emergence and spread of a multidrug-resistant Acinetobacter baumannii clone producing both the carbapenemase OXA-23 and the 16S rRNA methylase ArmAGioconda Brigante, Roberta Migliavacca, Simone Bramati, et al.
HIV Clinical Trials|July 11, 2007
Predictors of AIDS-defining events among advanced naïve patients after HAARTCarlo Torti, Giuseppe Lapadula, Franco Maggiolo, et al.
Antiviral Therapy|October 12, 2007
Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3Giuseppe Lapadula, Carlo Torti, Franco Maggiolo, et al.
The Journal of Antimicrobial Chemotherapy|April 17, 2007
CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral loadCarlo Torti, Giuseppe Lapadula, Pablo Barreiro, et al.
Antiviral Therapy|April 4, 2020
Real-life use of elbasvir/grazoprevir in adults and elderly patients: a prospective evaluation of comedications used in the PITER cohortMaria Giovanna Quaranta, Stefano Rosato, Luigina Ferrigno, et al.
Expert Review of Anti-Infective Therapy|August 17, 2020
Efficacy and safety of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs) and other infections in a real-life setting: data from an Italian observational multicentric study (DALBITA study)Francesca Bai, Chiara Aldieri, AnnaMaria Cattelan, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The New England Journal of Medicine|October 30, 2014
Brain abscessSebastiano Leone, Guglielmo Migliorino, Andrea Gori
The Journal of Antimicrobial Chemotherapy|March 12, 2011
Lung cryptococcosis in a treated HIV-1-infected patient with suppressed viral load and past disseminated cryptococcosis: relapse or late IRIS?Alessandro Soria, Monica Airoldi, Guglielmo Migliorino, et al.
Folia Neuropathologica|October 2, 2012
Primary angiitis of the central nervous system: 2 atypical casesFabio Pagni, Giuseppe Isimbaldi, Francesco Vergani, et al.
BMC Research Notes|August 8, 2014
The CCR5Δ32 allele is not a major predisposing factor for severe H1N1pdm09 infectionManuela Sironi, Rachele Cagliani, Chiara Pontremoli, et al.
Journal of Medical Microbiology|January 28, 2012
Emergence and spread of a multidrug-resistant Acinetobacter baumannii clone producing both the carbapenemase OXA-23 and the 16S rRNA methylase ArmAGioconda Brigante, Roberta Migliavacca, Simone Bramati, et al.
HIV Clinical Trials|July 11, 2007
Predictors of AIDS-defining events among advanced naïve patients after HAARTCarlo Torti, Giuseppe Lapadula, Franco Maggiolo, et al.
Antiviral Therapy|October 12, 2007
Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3Giuseppe Lapadula, Carlo Torti, Franco Maggiolo, et al.
The Journal of Antimicrobial Chemotherapy|April 17, 2007
CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral loadCarlo Torti, Giuseppe Lapadula, Pablo Barreiro, et al.
Antiviral Therapy|April 4, 2020
Real-life use of elbasvir/grazoprevir in adults and elderly patients: a prospective evaluation of comedications used in the PITER cohortMaria Giovanna Quaranta, Stefano Rosato, Luigina Ferrigno, et al.
Expert Review of Anti-Infective Therapy|August 17, 2020
Efficacy and safety of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs) and other infections in a real-life setting: data from an Italian observational multicentric study (DALBITA study)Francesca Bai, Chiara Aldieri, AnnaMaria Cattelan, et al.
Pageof 2